Craniomaxillofacial implants are vital in treating facial and cranial issues, addressing trauma, congenital deformities, and diseases affecting the face and skull. Utilizing materials such as titanium, these implants provide structural support for reconstructive surgeries, restoring facial aesthetics. Microtia, a congenital deformity, occurs in 8,000-10,000 births, with male children more affected. The right side is more common. Each case is unique, often requiring multiple procedures over the years. Increasing cases of congenital facial deformities are expected to boost the global craniomaxillofacial implants market, reflecting the growing prevalence of such conditions worldwide.
Access Full Report @ https://www.databridgemarketresearch.com/ru/reports/global-craniomaxillofacial-implants-market
Data Bridge Market Research analyses that the Global Craniomaxillofacial Implants Market is expected to grow at a CAGR of 7.40% in the forecast period of 2022 to 2029 and is expected to reach USD 2.52 billion by 2029 from USD 1.42 billion in 2021. The increasing global aging population contributes to a higher incidence of conditions necessitating craniomaxillofacial interventions. With a rise in fractures and age-related deformities, there is a growing demand for craniomaxillofacial implants, driving market growth as healthcare needs evolve to meet the challenges associated with an older demographic.
Key Findings of the Study
Patient preference for minimally invasive procedures is expected to drive the market's growth rate
A growing preference for minimally invasive procedures is evident among patients, fueled by advanced implant technologies. This trend aligns with the desire for less invasive interventions, offering quicker recovery times. The appeal lies in reduced postoperative discomfort and shorter hospital stays. As patients increasingly prioritize these benefits, the demand for craniomaxillofacial implants, supporting minimally invasive approaches, experiences a surge, driving notable growth in the market for these advanced medical interventions.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
Segments Covered
|
Type (Mid Face, Plates, Screws, Mandibular Orthognathic Implants, Neuro, Mesh, Bone Graft, Dural Repair)), Material of Construction (Calcium Phosphate Ceramics, Titanium, Alloys And Other Metals, Polymers Or Biomaterials), Material of Application Site (Internal Fixators, External Fixators), Property (Resorbable Fixators, Non-Resorbable Fixators)
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
Market Players Covered
|
Zimmer Biomet (U.S.), Stryker (U.S.), Medartis AG (Switzerland), KLS Martin Group (Germany), DePuy Synthes (a Johnson & Johnson company) (U.S.), Osteomed (U.S.), Integra Life Sciences Corporation (U.S.), Medtronic (Ireland), Calavera Surgical Design (U.S.), B. Braun Melsungen AG (Germany), General Implants GmbH (Germany), Rebstock Instruments GmbH (Germany), BIOPORE Surgical Implants (Mexico), Poriferous, LLC (U.S.), Osteotec (U.K.), Johnson & Johnson Services, Inc. (U.S.), Anatomics Pty. Ltd. (Australia) among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global craniomaxillofacial implants market is segmented on the basis of type, material of construction, material of application site, and property.
- On the basis of type, the global craniomaxillofacial implants market is segmented into at bone graft substitute, mid-face implants, cranial/neuro implants, mandibular orthognathic implants, distraction system, cranial flap fixation systems, patient specific implants (PSI), total temporomandibular (TMJ) replacement system, dural repair products, and others. Bone graft substitute is expected to dominate the craniomaxillofacial implants market with 30.10% market share due to an increase in the geriatric population globally
The bone graft substitute of the type segment is expected to dominate the global craniomaxillofacial implants market
Bone graft substitute is expected to dominate the global craniomaxillofacial implants market with a 30.10% market share due to an increase in the geriatric population globally. As age-related cranial and facial conditions escalate, the demand for effective solutions, including bone graft substitutes, is on the rise. These substitutes play a pivotal role in addressing bone defects, fractures, and deformities, making them a key contributor to the evolving landscape of craniomaxillofacial interventions.
- On the basis of material of construction, the global craniomaxillofacial implants market is segmented into metal, bone graft substitute, polymers/biomaterial, and others. Metal segment is expected to dominate the global craniomaxillofacial implants market with a 45.53% market share due to increasing technological advancement and healthcare expenditure government
- On the basis of material of application site, the global craniomaxillofacial implants market is segmented into external fixators and internal fixators. External fixators is expected to dominate the global craniomaxillofacial implants market with 88.25% market share due to the increasing product launches and acquisition
The external fixators of material of application site are expected to dominate the global craniomaxillofacial implants market
External fixators are expected to dominate the global craniomaxillofacial implants market with an 88.25% market share due to the increasing product launches and acquisitions. As external fixators gain prominence for their efficacy in craniomaxillofacial interventions, this market segment is positioned for sustained growth, reflecting the evolving landscape of medical technologies.
- On the basis of property, the global craniomaxillofacial implants market is segmented into resorbable fixators and non-resorbable fixators. In 2022, resorbable fixators are expected to dominate the global craniomaxillofacial implants market with a 68.44% market share as they provide better results in fewer complications
Major Players
Data Bridge Market Research recognizes the following companies as the major global craniomaxillofacial implants market players in global craniomaxillofacial implants market are Zimmer Biomet (U.S.), Stryker (U.S.), Medartis AG (Switzerland), KLS Martin Group (Germany), DePuy Synthes (a Johnson & Johnson company) (U.S.), Osteomed (U.S.), Integra Life Sciences Corporation (U.S.), Medtronic (Ireland), Calavera Surgical Design (U.S.)
Market Developments
- In June 2022, Ricoh USA, Inc. achieved a significant milestone by securing 510(k) clearance from the U.S. Food and Drug Administration (FDA) for RICOH 3D. This advanced technology encompasses patient-specific anatomic modeling for craniomaxillofacial (CMF) and orthopedic applications, showcasing Ricoh's commitment to cutting-edge healthcare solutions
- In February 2022, DePuy Synthes, a Johnson & Johnson subsidiary, bolstered its orthopedic portfolio through the acquisition of CrossRoads Extremity Systems. This Tennessee-based company specializes in foot and ankle solutions, providing a diverse array of procedure-specific, sterile-packed implants, and instrumentation systems. The strategic acquisition enhances DePuy Synthes' position in the orthopedic market, particularly in lower extremity indications, reflecting their dedication to advancing musculoskeletal care
Regional Analysis
Geographically, the countries covered in the global craniomaxillofacial implants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in the global craniomaxillofacial implants market during the forecast period 2022-2029
North America dominates the global craniomaxillofacial implants market, leading in both market share and revenue. The region's continued dominance is attributed to rising healthcare expenditure and a surge in sports-related injuries, as well as injuries affecting cranial and facial bones. The robust healthcare infrastructure and technological advancements further bolster the market's growth trajectory, ensuring North America's sustained prominence in the craniomaxillofacial implants sector throughout the forecast period.
Asia-Pacific is estimated to be the fastest growing region in the global craniomaxillofacial implants market during the forecast period 2022-2029
Asia-Pacific is expected to dominate the global craniomaxillofacial implants market, exhibiting the highest growth rate in the forecast period. This is attributed to factors such as the rising incidence of road accidents, a surge in sports injuries, and the increasing aging population in the region. As healthcare needs evolve, the demand for craniomaxillofacial interventions is anticipated to escalate, positioning Asia-Pacific as a key contributor to the expanding market.
For more detailed information about the global craniomaxillofacial implants market report, click here – https://www.databridgemarketresearch.com/ru/reports/global-craniomaxillofacial-implants-market